Preparation method of medical intermediate

An intermediate and pharmaceutical technology, applied in the field of compound preparation, can solve problems such as high solvent consumption, many impurities, and the impact of feeding accuracy

Inactive Publication Date: 2021-10-08
HUNAN FANGSHENG PHARMACEUTICAL CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Go directly to the next step reaction without purification, obviously more impurities are brought in, which will affect the yield and purity of the next step product
Purification by column chromatography to obtain intermediate 2, on the one hand, column chromatography is not convenient for industrial production, the solvent consumption is high, and the environment is not friendly; to affect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Add 153g of toluene to a 1L reaction flask, add 25g of intermediate 1 under stirring, and then add 11.78g of tetrabutylammonium bisulfate and about 40% potassium hydroxide aqueous solution. The temperature of the system was lowered to 5-10°C, and 12 g of tert-butyl bromoacetate was added dropwise at 7°C. Control the temperature at 5-10°C, stir for 45 minutes, then raise the system to room temperature, control the temperature at 23-25°C and stir for 1 hour. TLC monitoring (n-hexane: ethyl acetate = 2:1), the reaction of raw materials was complete. Add 150g of water, then add 160g of ethyl acetate for extraction and phase separation, collect the organic phase and wash with 152g of water for phase separation. After concentrating, 32 g of reddish-brown oil was obtained. Add 28ml of benzyl alcohol and 8ml of n-propanol to the oil, stir to dissolve, then add 160ml of n-heptane, the system is cloudy, heat to reflux to dissolve, then stir and cool down to 10-20°C, keep warm a...

Embodiment 2

[0023] Add 153g of toluene to the 1L reaction flask, add 25g of intermediate 1 under stirring, then add 11.78g of tetrabutylammonium bisulfate and about 40% potassium hydroxide aqueous solution (116g of potassium hydroxide is added to 174g of drinking water, stir to dissolve ). The temperature of the system was lowered to 5-10°C, and 12 g of tert-butyl bromoacetate was added dropwise at 7°C. Control the temperature at 5-10°C, stir for 45 minutes, then raise the system to room temperature, control the temperature at 23-25°C and stir for 1 hour. TLC monitoring (n-hexane: ethyl acetate = 2:1), the reaction of raw materials was complete. Add 150g of water, then add 160g of ethyl acetate for extraction and phase separation, collect the organic phase and wash with 152g of water for phase separation. After concentrating, 32 g of oily substance was obtained. Add 48ml of n-propanol to the oil, stir to dissolve, then add 240ml of n-hexane, the system becomes cloudy, heat to reflux to...

Embodiment 3

[0025] Add 153g of toluene to a 1L reaction flask, add 25g of intermediate 1 under stirring, and then add 11.78g of tetrabutylammonium bisulfate and about 40% potassium hydroxide aqueous solution. The temperature of the system was lowered to 5-10°C, and 12 g of tert-butyl bromoacetate was added dropwise at 7°C. Control the temperature at 5-10°C, stir for 45 minutes, then raise the system to room temperature, control the temperature at 23-25°C and stir for 1 hour. TLC monitoring (n-hexane: ethyl acetate = 2:1), the reaction of raw materials was complete. Add 150g of water, then add 160g of ethyl acetate for extraction and phase separation, collect the organic phase and wash with 152g of water for phase separation. After concentrating, 32 g of oily substance was obtained. Add 48ml of n-butanol to the oil, stir to dissolve, then add 240ml of n-hexane, the system becomes cloudy, heat to reflux to dissolve, then stir and cool down to 10-20°C, keep warm and crystallize for 1-2 hou...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of a medical intermediate tert-butyl 2-{4-[(5, 6-diphenylpyrazine-2-yl)(propane-2-yl)amino]butoxy}acetate. The method can obtain a high-purity product through a specific recrystallization method, thereby being beneficial to industrial production and improving the yield of subsequent reaction. According to the crystallization method, a mixed solvent composed of hydrocarbon and alcohol is used, the hydrocarbon is selected from one or more of n-hexane, cyclohexane, n-heptane, methylbenzene and xylene, and the alcohol is selected from one or more of propyl alcohol, isopropyl alcohol, n-butyl alcohol, isobutyl alcohol and benzyl alcohol.

Description

technical field [0001] The invention relates to the field of compound preparation, in particular to a preparation method of a pharmaceutical intermediate. Background technique [0002] Selexipag, English name Selexipag, chemical name 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}-N-(methyl Sulfonyl) acetamide is an excellent PGI2 receptor stimulator, which has multiple effects such as platelet aggregation inhibition, vasodilation, bronchial muscle expansion, lipid precipitation inhibition, and leukocyte activation inhibition. A good medicine for high pressure, which was launched in China in 2018, and is in great demand. [0003] Synthesis of Selexipag requires an intermediate, chemical name tert-butyl 2-{4-[(5,6-diphenylpyrazin-2-yl)(propan-2-yl)amino]butoxy}acetate Esters (hereinafter referred to as intermediate 2), which are formed from 2-{4-[(5,6-diphenylpyrazin-2-yl)(propane-2-yl)amino]butanol (intermediate 1) After etherification reaction, it is a substit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D241/20
CPCC07D241/20
Inventor 侯瑛徐汨
Owner HUNAN FANGSHENG PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products